HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope Journal Article
| Authors: | Fera, D.; Lee, M. S.; Wiehe, K.; Meyerhoff, R. R.; Piai, A.; Bonsignori, M.; Aussedat, B.; Walkowicz, W. E.; Ton, T.; Zhou, J. O.; Danishefsky, S.; Haynes, B. F.; Harrison, S. C. |
| Article Title: | HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope |
| Abstract: | HIV-1 envelope (Env) mimetics are candidate components of prophylactic vaccines and potential therapeutics. Here we use a synthetic V3-glycopeptide ("Man9-V3") for structural studies of an HIV Env third variable loop (V3)-glycan directed, broadly neutralizing antibody (bnAb) lineage ("DH270"), to visualize the epitope on Env and to study how affinity maturation of the lineage proceeded. Unlike many previous V3 mimetics, Man9-V3 encompasses two key features of the V3 region recognized by V3-glycan bnAbs-The conserved GDIR motif and the N332 glycan. In our structure of an antibody fragment of a lineage member, DH270.6, in complex with the V3 glycopeptide, the conformation of the antibody-bound glycopeptide conforms closely to that of the corresponding segment in an intact HIV-1 Env trimer. An additional structure identifies roles for two critical mutations in the development of breadth. The results suggest a strategy for use of a V3 glycopeptide as a vaccine immunogen. © 2018 The Author(s). |
| Keywords: | unclassified drug; genetics; mutation; nonhuman; human immunodeficiency virus infection; protein conformation; protein motif; immune system; peptide; virology; immunology; chemistry; epitope mapping; epitope; crystal structure; models, molecular; human immunodeficiency virus; antibody; vaccine; glycopeptide; molecular model; hiv infections; human immunodeficiency virus 1; amino acid motifs; hiv-1; epitopes; maturation; neutralizing antibody; antibodies, neutralizing; glycan; hiv antibodies; virus envelope protein; antibody structure; humans; human; article; human immunodeficiency virus antibody; gene products, env; v 3 glycopeptide |
| Journal Title: | Nature Communications |
| Volume: | 9 |
| ISSN: | 2041-1723 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2018-03-16 |
| Start Page: | 1111 |
| Language: | English |
| DOI: | 10.1038/s41467-018-03565-6 |
| PUBMED: | 29549260 |
| PROVIDER: | scopus |
| PMCID: | PMC5856820 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 May 2018 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
17Aussedat -
539Danishefsky
Related MSK Work